Streetbeat News

Analyst Ratings

TBPH

HC Wainwright & Co. analyst Douglas Tsao has reiterated a 'Buy' rating on Theravance Biopharma (NASDAQ:TBPH) and maintained a $20 price target.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 10:15 am

UUUU

HC Wainwright & Co. analyst Heiko Ihle maintains a 'Buy' rating on Energy Fuels (AMEX:UUUU) and raises the price target from $9.75 to $10.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 10:13 am

SAGE

HC Wainwright & Co. analyst Douglas Tsao has maintained a Neutral rating on Sage Therapeutics (NASDAQ:SAGE) and lowered the price target from $50 to $27.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 10:12 am

BOLT

HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on Bolt Biotherapeutics (NASDAQ:BOLT) and maintained an $8 price target.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 10:11 am

NXTC

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on NextCure (NASDAQ:NXTC) with a Buy rating and announces a price target of $7.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 10:11 am

DCGO

Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a price target of $14.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 10:10 am

COMP

Needham analyst Bernie McTernan has reiterated a 'Buy' rating on Compass (NYSE:COMP) and maintained a price target of $5.5.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 10:09 am

ASUR

Needham analyst Joshua Reilly has reiterated a 'Buy' rating on Asure Software (NASDAQ:ASUR) and maintained a price target of $20.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 10:08 am

WLK

JP Morgan analyst Jeffrey Zekauskas has downgraded Westlake (NYSE:WLK) from Neutral to Underweight and raised the price target from $120 to $123.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 9:37 am

TROX

Credit Suisse analyst John Roberts has upgraded Tronox Holdings (NYSE:TROX) from Underperform to Neutral and raised the price target from $12 to $13.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 9:35 am